Further to our letter dated 24th January, 2019, we would like to inform that the Board of Directors of the Company at its meeting held on today has approved Un-audited Financial Results for the first quarter ended 31st December, 2018 In terms of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith the following: 1. Un-audited Standalone Financial Results for the third quarter ended 31st December, 2018. 2. Limited Review Report on the Standalone Financial Results The Board meeting commenced at 15:00 Hrs and concluded at 16:00 Hrs We request you to take the same on records.

Pdf Link: Shree Ganesh Biotech (India) Ltd - Submission Of Audited Financial Result For Quarter Ended 31St December, 2018 Pursuant To Regulation 33 Of The SEBI (LODR) Regulations, 2015

Source : BSE - www.bseindia.com